Most Popular

Should Investors Buy Weakness in These High-Growth Stocks?

The 2024 Q3 earnings season continues at a rapid pace, with a nice variety of companies delivering quarterly results daily. So far, several popular stocks, namely Advanced Micro Devices AMD and Eli Lilly LLY – have reported quarterly results, with the two seeing negative post-earnings …

Read more

The Data Keep Screaming “Small Caps”

Consumers keep spending … the tailwinds Louis sees pushing small caps higher … Jason’s bullish take on small caps … a retirement “accelerator” has opened “If there’s one thing I’ve learned in my 47-year career in the market, it’s that you should never doubt the …

Read more

Reddit Vs. Snap: Election Buzz, Bullish Signals Propel RDDT Past SNAP In Market Value – Reddit (NYSE:RDDT), Snap (NYSE:SNAP)

Reddit Inc RDDT has turned the tables on Snap Inc SNAP in social media rankings, climbing 12% on Election Day to reach a market cap of $21.5 billion, ahead of Snap’s $20.4 billion. This milestone is a striking achievement for Reddit, which, despite having one-fourth …

Read more

These Analysts Revise Their Forecasts On Revvity Following Q3 Results – Revvity (NYSE:RVTY)

Revvity, Inc. RVTY reported better-than-expected third-quarter earnings on Monday. The company posted quarterly earnings of $1.28 per share which beat the analyst consensus estimate of $1.13 per share. The company reported quarterly sales of $684.05 million which beat the analyst consensus estimate of $679.65 million. …

Read more

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 – CARISMA Therapeutics (NASDAQ:CARM), Moderna (NASDAQ:MRNA)

Pre-clinical data demonstrate robust anti-tumor activity and a novel off-the-shelf approach for GPC3+ solid tumors PHILADELPHIA, Nov. 5, 2024 /PRNewswire/ — Carisma Therapeutics Inc. CARM (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the upcoming presentation of new …

Read more

These 2 Stocks Are Nvidia’s Most Serious Competitors. But Are They Even Close?

For the last two years, it’s been nearly impossible to tune intofinancial newsprograms or click on an article about a stock and not come across the words “artificial intelligence (AI).” AI is everywhere, and it appears that it’s here to stay. Among the hottest of …

Read more

Why Oklo Stock Skyrocketed 178% in October

Oklo (NYSE: OKLO) isn’t a household name by any stretch, but the nuclear stock was popping up on investors’ radars last month as it soared on related sector news. Oklo is a development-stage company, backed by OpenAI CEO Sam Altman, and it doesn’t have any …

Read more

GM Stock Hits 52-Week High on Blowout Q3: Hold or Lock Profits?

U.S. legacy automaker General Motors GM delivered stellar third-quarter results yesterday, which drove its shares to a 52-week high. The stock rose nearly 10%, marking its biggest daily percentage gain since 2020, as the company outpaced Wall Street’s expectations and raised its full-year 2024 guidance …

Read more

1 Chart That Shows Why Tesla Is Still Overvalued

After a forgettable 2023, Tesla (NASDAQ: TSLA) finally scored some redemption in its third-quarter earnings report last week. The stock soared 22% in a single day on Thursday, its best one-day performance in years as it overcame tepid sales growth in its automotive division to …

Read more

Harvesting Returns: Pick 2 Stocks To Gain from Rising Food Demand

I know things feel pretty tense right now. But don’t be pulled into the trap of thinking everything is up in the air these days. Truth is, there are always rock-solid trends out there that no one can change. I’m talking about sure things that …

Read more